Title
Category
Credits
Event date
Cost
Medication Assisted Treatments for Opiates, But What About Stimulants?
  • S.U.D
  • 1.00 AAFP Prescribed
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 AOA Category 2-A
$0.00
This activity is part of CAFP's California Residency Program Collaborative around improving education, outreach and treatment for patients with substance use disorder disease, including stimulants and opioids, with a focus on medication assisted treatment options.Learning Objective:At the end of this session, learners should be able to:
Telehealth for Substance Use
  • S.U.D
  • 0.50 AAFP Prescribed
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 AOA Category 2-A
$0.00
This activity is part of CAFP's California Residency Program Collaborative around improving education, outreach and treatment for patients with substance use disorder disease, including stimulants and opioids, with a focus on medication assisted treatment options. Learning Objectives:At the end of this session, participants should be able to:
Pregnancy and Women’s SUD
  • S.U.D
  • Women's Health
  • 0.75 AAFP Prescribed
  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 AOA Category 2-A
$0.00
This activity is part of CAFP's California Residency Program Collaborative around improving education, outreach and treatment for patients with substance use disorder disease, including stimulants and opioids, with a focus on medication assisted treatment options.Learning Objectives:After this course, participants should be able to:
Communication Matters: Motivational Interviewing and Substance Use Disorders
  • S.U.D
  • 0.75 AAFP Prescribed
  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 AOA Category 2-A
$0.00
This activity is part of CAFP's California Residency Program Collaborative around improving education, outreach and treatment for patients with substance use disorder disease, including stimulants and opioids, with a focus on medication assisted treatment options. Learning Objectives:At the end of this session, learners should be able to:
Screening and Identifying Opioid Use and Substance Use Disorders
  • S.U.D
  • 0.50 AAFP Prescribed
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 AOA Category 2-A
$0.00
This activity is part of CAFP's California Residency Program Collaborative around improving education, outreach and treatment for patients with substance use disorder disease, including stimulants and opioids, with a focus on medication assisted treatment options.Learning Objective:At the end of this session, learners should be able to:
Increasing Physician Efficiency: Eliminating the WAC
  • Miscellaneous
$0.00
Everyone talks about the barriers caused by the EHR, about hours spent entering data, about time after clinic which could be spent with family. Using what’s she’s learned in her practice, Karen Muchowski will share tips on changes YOU can make as an individual to improve your efficiency, so you can eliminate the Work After Clinic (WAC).Learning Objective:At the end of this session, learners should be able to:
Call to Action: The Time for Treating Substance Use Disorder Is Now
  • S.U.D
$0.00
This program will help overcome barriers to California providers wishing to begin offering Medication for Opioid Use Disorder (MOUD) and provide effective education to all interested family physicians. Patient-facing healthcare providers will learn to recognize OUD stigma, communicate more effectively, and be more confident in choosing MOUD.
The Time for Treating Substance Use Disorder Is Now
  • S.U.D
  • 1.00 AAFP Prescribed
  • 1.00 AMA PRA Category 1 Credit™
$0.00
People with substance use disorders (SUD) are coming to the office, whether we know it or not. Let's treat SUD/OUD (opioid use disorder) as we would treat any other medical condition: with compassion and good medicine. In this webinar you’ll learn to recognize stigma, communicate more effectively, and be more confident in choosing Medication for OUD (MOUD). Addiction medicine is family medicine.Learning Objective:At the end of this session, learners should be able to:Identify common barriers to health care practitioners beginning MOUD
Break the Stigma, Save a Life
  • S.U.D
  • 1.00 AAFP Prescribed
  • 1.00 AMA PRA Category 1 Credit™
$0.00
While gains have been made in reducing stigma around certain conditions, like depression and obesity, little progress has been made in removing the stigma around substance use disorders. The public and even health care providers continue to blame patients for their disease even though there is clear consensus that addiction is a complex brain disorder and not the result of moral weakness and flawed character.When people with addiction are stigmatized and rejected, especially by those within healthcare, it only contributes to the vicious cycle that entrenches their disease.
Prescribing Medication for Opioid Use Disorder
  • S.U.D
  • 1.00 AAFP Prescribed
  • 1.00 AMA PRA Category 1 Credit™
$0.00
Dr. Trotzky-Sirr will explain the three medicines typically prescribed for OUD, and guide you through specific resources and protocols so you can get started saving lives right away.Learning Objectives:At the end of this session, learners should be able to:Describe different modalities of initiating MOUD in the setting of fentanylIdentify which patients are appropriate for primary care management versus those who need a referral to addiction specialists

Pages